MedPath

Preoperative Maximum Inspiratory Pressure and Outcomes After Interscalene Block in Obese Patients

Completed
Conditions
Dyspnea After Interscalene Nerve Block
Registration Number
NCT06549244
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The study aims to explore if Maximum Inspiratory Pressure can predict postoperative breathlessness in obese patients receiving interscalene blocks for shoulder surgery.

The main question is: does baseline Maximum Inspiratory Pressure have any association with postoperative breathlessness after interscalene blocks in class 2 or higher obese patients (BMI\>35).

Preoperative and postoperative lung volumes, pressures, breathlessness score and respiratory outcomes will be measured on participants already receiving shoulder surgery with interscalene blocks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of Moderate to Severe BreathlessnessBaseline (Arrival to pre-operative phase), Recovery (Immediately post-surgical, up to 3 hours)

Score of 3 or above on Modified Borg Breathlessness Scale

Secondary Outcome Measures
NameTimeMethod
Oxygen Saturation in post-anesthesia care unitRecovery (Immediately post-surgical, up to 3 hours)

Measured by pulse oximetry

Duration of Oxygen supplementation in post-anesthesia care unitRecovery (Immediately post-surgical, up to 3 hours)

Total duration of oxygen supplementation in post-operative phase of care

Post-anesthesia care unit length-of-stayRecovery (Immediately post-surgical, up to 3 hours)

Total time spent in post-operative phase of care

Trial Locations

Locations (1)

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

University of North Carolina
🇺🇸Chapel Hill, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.